Synthesis and cytotoxic activities of novel phenacylimidazolium bromides

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 7, 2009, Pages 1892-1895

  Yang, Xiao Dong ^a   Zeng, Xiang Hui ^a   Zhang, Yan Li ^b   Qing, Chen ^b   Song, Wen Jian ^a   Li, Liang ^a   Zhang, Hong Bin ^a  

^a YUNNAN UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxic activities; Phenacylimidazolium bromides; Structure activity relationships; Synthesis

Indexed keywords

CISPLATIN; IMIDAZOLE DERIVATIVE; PHENACYL CHLORIDE; PHENACYLIMIDAZOLIUM DERIVATIVE; PROGLYCOSYN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; STEREOCHEMISTRY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IMIDAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 61849166251     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.02.065     Document Type: Article

References (38)

1. Welton T. Chem. Rev. 99 (1999) 2071
2. Visser A.E., Swatloski R.P., and Rogers R.D. Green Chem. 2 (2002) 1
3. Marion N., Diez-Gonzalez S., and Nolan S.P. Angew. Chem., Int. Ed. 46 (2007) 2988
4. In: Nolan S.P. (Ed). N-Heterocyclic Carbenes in Synthesis (2006), Wiley-VCH, Weinheim, Germany
5. Crudden C.M., and Allen D.P. Coord. Chem. Rev. 248 (2004) 2247
6. Peris E., and Crabtree R.H. Coord. Chem. Rev. 248 (2004) 2247
7. Cesar V., Bellemin-Laponnaz S., and Gade L.H. Chem. Soc. Rev. 33 (2004) 619
8. Hahn F.E. Angew. Chem., Int. Ed. 45 (2006) 1384
9. Diez-Gonzalez S., and Nolan S.P. Coord. Chem. Rev. 251 (2007) 874
10. Wong F.T., Patra P.K., Seayad J., Zhang Y., and Ying J.Y. Org. Lett. 10 (2008) 2333
11. Vik A., Hedner E., Charnock C., Tangen L.W., Samuelsen Ø., Larsson R., Bohlinb L., and Gundersen L.L. Bioorg. Med. Chem. 15 (2007) 4016
12. Demberelnyamba D., Kim K.S., Choi S., Park S.Y., Lee H., Kim C.J., and Yoo I.D. Bioorg. Med. Chem. 12 (2004) 853
13. Pernak J., Skrzypzzak A., Kucharski S., and Krysinski J. Arch. Pharm. 317 (1984) 430
14. Fortuna C.G., Barresi V., Berellini G., and Musumarra G. Bioorg. Med. Chem. 16 (2008) 4150
15. Ballistreri F.P., Barresi V., Benedetti P., Caltabiano G., Fortuna C.G., Longo M.L., and Musumarraa G. Bioorg. Med. Chem. 12 (2004) 1689
16. Miyachi H., Kiyota H., and Segawa M. Bioorg. Med. Chem. Lett. 9 (1999) 3003
17. Iizuka, K.; Kamijo, T.; Yamamoto, R.; Harada, H. U.S. Patent 4,461,905, 1984.
18. Haugwitz; R. D.; Narayanan; V. L. U.S. Patent 3,852,301, 1974.
19. Lis R., Morgan Jr. T.K., DeVita R.J., Davey D.D., Lumman Jr. W.C., Wohl R.A., Diamond J., Wong S.S., and Sullivan M.E. J. Med. Chem. 30 (1987) 696
20. Li Q.L., Huang J., Wang Q., Jiang N., Xia C.Q., Lin H.H., Wua J., and Yu X.Q. Bioorg. Med. Chem. 14 (2006) 4151
21. Dominianni S.J., and Yen T.T. J. Med. Chem. 32 (1989) 2301
22. Yen T.T., Dominianni S.J., Harris R.A., and Stephens T.W. In: Bailey C.J., and Flatt P.R. (Eds). New Antidiabetic Drugs (1990), Smith-Gordon, London 245-247
23. Harris R.A., Yamanouchi K., Roach P.J., Yen T.T., Dominianni S.J., and Stephens T.W. J. Biol. Chem. 264 (1989) 14674
24. Guo Z., Wals P.A., and Katz J. J. Biol. Chem. 266 (1991) 22323
25. Agius L. Biochem. J. 325 (1997) 667
26. Chivikas C.J., and Hodges J.C. J. Org. Chem. 52 (1987) 3591
27. Cui B., Zheng B.L., He K., and Zheng Q.Y. J. Nat. Prod. 66 (2003) 1101
28. Zhao Y.H., Zhou Y.Y., Ma D.D., Liu J.P., Li L., Zhang T.Y., and Zhang H.B. Org. Biomol. Chem. 1 (2003) 1643
29. Liu J.P., Zhao Y.H., Zhou Y.Y., Li L., Zhang T.Y., and Zhang H.B. Org. Biomol. Chem. 1 (2003) 3227
30. Zhang T.Y., and Zhang H.B. Tetrahedron Lett. 43 (2002) 193
31. Zhang, H. B.; Yang, X. D.; Qing, C.; Liu, Y. L.; Li, L.; Liu, J. P. Chin. Patent ZL200610011025.7, 2008.
32. Yang X.D., Li L., and Zhang H.B. Helv. Chim. Acta 91 (2008) 1435
33. Liu J.P., Chen J.B., Zhou Y.Y., Li L., and Zhang H.B. Synthesis (2003) 2661
34. Liu J.P., Ren Z.Y., Zhou Y.Y., and Zhang H.B. Chin. J. Org. Chem. 24 (2004) 1091
35. General procedure for the preparation of N-arylimidazoles 4a-4u. Method A: see Ref. 16, yield 4g 80%, 4i 85% and 4n 78%. Method B: see Ref. 17, yield 4a 82%, 4c 60%, 4e 43% and 4m 24%.
36. 2O 434.0994, found 434.0992.
37. Kim D.-K., Ryu D.H., Lee J.Y., Lee N., Kim Y.-W., Kim J.-S., Chang K., Im G.-J., Kim T.-K., and Choi W.-S. J. Med. Chem. 44 (2001) 1594
38. Cao R., Chen Q., Hou X., Chen H., Guan H., Ma Y., Peng W., and Xu A. Bioorg. Med. Chem. 12 (2004) 4613